Investors | Natrox - Oxygen Wound Therapy

Investors

Cambridge Capital Group

Cambridge Capital Group is a leading business angel group of 40 investors that have been investing in hi-tech businesses for ten years.
www.cambridgecapitalgroup.co.uk

Cambridge Enterprise

Cambridge Enterprise Limited is a wholly owned subsidiary of the University of Cambridge, responsible for the commercialisation of University intellectual property.
www.enterprise.cam.ac.uk

Cambridge Angels

The Cambridge Angels are a group of high-net worth investors who have proven experience as successful entrepreneurs in technology and bio-technology.
www.cambridgeangels.net

Amadeus Capital Partners

Amadeus Capital Partners is a global technology investor. Since its inception in 1997, the firm has raised over $1bn for investment and backed more than 100 companies in the software, mobile, internet, cyber security and medical technology sectors. The investment team is based in India, South Africa, Sweden, UK and USA, has deep experience in technology and invests in high-growth companies from early stage to pre-IPO.
www.amadeuscapital.com

Information for clinicians

Oxygen is critical to many of the processes required in wound healing. NATROX® Oxygen Wound Therapy allows you to prescribe topical oxygen in a very simple, safe and extremely convenient way directly to the wound bed.

Read more

Information for patients

NATROX® Oxygen Wound Therapy is a small portable device about the size of a mobile phone. Its function is to produce concentrated oxygen from the surrounding air, and pass this down a thin flexible tube directly to a wound that is failing to progress as expected.

Read more

Innovative wound care treatment

In a communications initiative with New NHS Alliance and ITN Productions, NATROX® Oxygen Wound Therapy was featured in their campaign to promote “Healthy Communities, Healthy People”.

More News & media